Twist Bioscience Corp (Twist Bioscience) is a synthetic biology company that carries out the development of synthetic DNA and synthetic DNA-based products. The company offers synthetic genes and gene fragments, oligonucleotide, IgG proteins, next-generation sequencing (NGS) tools, drug and target discovery solutions, and synthetic viral controls, infectious disease research tools. Its products are used to treat influenzas, rhinoviruses, respiratory syncytial virus, SARS, MERS and coronaviruses, among others. Twist Bioscience’s silicon-based DNA synthesis platform enables the sequencing process and the production of synthetic DNA tools. The company serves health care, food and agriculture, industrial chemicals and materials, academic research and technology sectors. It sells products through distributors, direct sales personnel, commercial consultants. The company operates in China, Israel, China, Singapore and the US. Twist Bioscience is headquartered in South San Francisco, California, the US.
Headquarters
United States of America
Address
681 Gateway Blvd., South San Francisco, California, 94080
Website
www.twistbioscience.com
Telephone
1 408 4100105
No of Employees
919
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
TWST (NASD)
Revenue (2022)
$245.1M
20.4%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
6.1%
(2022 vs 2021)
Market Cap*
$1.8B
Net Profit Margin (2022)
XYZ
22.0%
(2022 vs 2021)
* As of and is in US$
Twist Bioscience Corp premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Synthetic Biology | Antibody Development |
| Synthetic Genes and Gene Fragments | E-Commerce (Online Delivery) |
| Oligonucleotide | |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | New Products/Services | In March, the company introduced Twist Precision Dx next-generation sequencing (NGS) Products. |
| 2024 | New Products/Services | In March the company introduced a new Human Pangenome Spike-in for the Twist Exome 2.0 panel. |
| 2024 | New Products/Services | In February, the company introduced the Twist Flex Prep Ultra High-Throughput Kit. |
Competitor Comparison
| Key Parameters | Twist Bioscience Corp | Thermo Fisher Scientific Inc | Agilent Technologies Inc | Illumina Inc | Genscript Biotech Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | China |
| City | South San Francisco | Waltham | Santa Clara | San Diego | Nanjing |
| State/Province | California | Massachusetts | California | California | Jiangsu |
| No. of Employees | 919 | 122,000 | 17,700 | 10,590 | 6,937 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Emily M. Leproust, Ph.D. | Chairman; Chief Executive Officer | Executive Board | 2018 | 50 |
| William Banyai, Ph.D | General Manager - Data Storage; Director; Senior Vice President - Advanced Development | Executive Board | 2022 | 69 |
| Adam Laponis | Chief Financial Officer | Senior Management | 2024 | - |
| Patrick Finn, Ph.D | Chief Operating Officer; President | Senior Management | 2022 | 53 |
| Chet Gandhi | Chief Information Officer | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer